Impel Pharmaceuticals

Developing life-changing, innovative therapies for diseases with unmet needs

[Association of Migraine Disorders® @MigraineDisordr]

In 2021, the FDA approved a new way of delivering dihydroergotamine that targets the upper nasal space for migraine. Why is this novel delivery method unique & what #migraine types is it most effective for?

https://t.co/zwo2a1kcIm…

Article sponsored by @ImpelPharma

[Impel Pharmaceuticals @ImpelPharma]

Summer is a tough time of year for #migraine and #headaches. To best celebrate #freedom with your friends and family, be mindful of your triggers and keep your acute meds on hand.

Wishing everyone a safe and happy #IndependenceDay!

[Impel Pharmaceuticals @ImpelPharma]

Trudhesa® (DHE mesylate) delivers a trusted #migraine therapeutic to the vascular-rich upper nasal space via the POD® device. This results in IV-like efficacy at home - not via injection in an ER.

Learn more from @WebMD: https://t.co/fWuqPHSwxi

[Impel Pharmaceuticals @ImpelPharma]

The Impel team proudly supports the #migraine community. Today we're wearing our #ShadesForMigraine to raise awareness about this complex, neurological disease that's more than just a #headache.

#MHAM #MigraineAwareness @shades4migraine

[The Headache & Migraine Policy Forum @headachepolicy]

If you're at @ahsheadache's Scientific Meeting today, join HMPF at 3:30 CT for a claims data analysis of the effect of barriers to treatment access on emergency department usage by race/ethnicity in the U.S.

Learn more: https://t.co/yR0xW6bd0x

[Impel Pharmaceuticals @ImpelPharma]

A second poster on preliminary real-world data at #AHSAM underscores the need for non-oral treatment options for #migraine given the prevalence of pre-existing #gastrointestinal disorders among those prescribed with Trudhesa® (DHE mesylate).

[Impel Pharmaceuticals @ImpelPharma]

Preliminary real-world data at #AHSAM suggest that concomitant preventive & acute medication use generally decreases in patients taking Trudhesa® (DHE mesylate) nasal spray, and that use of antinausea medications (common with DHE administered via IV) did not increase.

[Nina Riggins, MD, PhD, FAAN, FAHS, UCNS Diplomate @NinaRiggins]

Excellent meeting #Women’s Health #AHSAM ⁦@ahsheadache⁩ Fantastic discussion #Migraine #Hormones #AHSFirstContact collaboration ⁦@WNGtweets⁩ ⁦@AANmember⁩ ❤️🧠⁦@miles4migraine⁩ #EMC

[Impel Pharmaceuticals @ImpelPharma]

We’re presenting new real-world data at #AHSAM suggesting concomitant preventive & acute medication use decreases in patients with #migraine using Trudhesa® (DHE mesylate) nasal spray.

Learn more about our data: https://t.co/1TgieJ2Ozk
#NeuroTwitter #MHAM

[Impel Pharmaceuticals @ImpelPharma]

#Migraine diaries are also a great tool to evaluate how your current meds are working for you, and to arm yourself with the information needed to become a self-advocate. Thanks @NHF! #MHAM

[National Headache Foundation (NHF) @NHF]

We're over a week into #MHAM and today we're discussing a headache diary.
This is helpful for those with migraine or headache to understand their headache history. Patterns in the diary helps a doctor determine the type of headache a patient has and recommend treatment.

[CoalitionCHAMP @CoalitionCHAMP]

During #MHAM, we honor those we’ve lost to migraine/headache disease. Please light a candle or light your home with a purple light today at 6pm ET in remembrance. Then take a picture and share it on social media with #ShineALight. #mham2023 #EducateYourself #EducateOthers

[Impel Pharmaceuticals @ImpelPharma]

We’re kicking off #MHAM with a MUST READ on Migraine At Work Day. Published in 2021 by @HarvardBiz, Dr. Olivia Begasse de Dhaem’s (@obegassededhaem) article outlines research-backed strategies to help raise awareness and support employees with #migraine. https://t.co/XIBZ1moS9z

[Impel Pharmaceuticals @ImpelPharma]

This morning we're reporting our Q1 2023 financial results and providing a business update.

Join our live webcast TODAY at 8:30am ET to discuss them. Access the webcast, slides, and replay here: https://t.co/CIzCzv9luU

Press release: https://t.co/r9fRWh006f
$IMPL

[Impel Pharmaceuticals @ImpelPharma]

Join us on TOMORROW at 8:30am ET to learn more about our Q1 2023 #earnings and business updates. A replay of the webcast and accompanying slides will be available on our website following.

Access the live conference call by registering: https://t.co/CIzCzv9luU
$IMPL

[Impel Pharmaceuticals @ImpelPharma]

This morning we announced the appointment of Michael Kalb as Chief Financial Officer, effective immediately. Read our press release to learn more about his broad corporate and financial experience and plans to continue creating value for our shareholders: https://t.co/IRd6UxHk2Q

[Impel Pharmaceuticals @ImpelPharma]

Today at #AANAM we’re presenting an analysis in a small population from our pivotal STOP 301 study in acute #migraine that found no significant safety concerns emerged from off-protocol, concomitant use of triptans and Trudhesa.

Abstract: https://t.co/WQg0s1iJuf

[Impel Pharmaceuticals @ImpelPharma]

Today at #AANAM we’re presenting an analysis using a model-based approach that found no DDIs of clinical concern are theoretically predicted if Trudhesa and gepants are co-administered within recommended clinical doses.

Abstract: https://t.co/kgug5Po77C
#NeuroTwitter #migraine

[Impel Pharmaceuticals @ImpelPharma]

Stop by our booth #1778 at #AANAM to learn about our latest #migraine data.

#AAN23 #BrainHealth #NeuroTwitter @AANMember

[Impel Pharmaceuticals @ImpelPharma]

We’re presenting a range of new data at #AANAM suggesting Trudhesa is safe to use when co-administered with commonly prescribed migraine mediations, including a new analysis that predicts no DDIs when co-administered with #gepants.

Learn more: https://t.co/l3TMPPGTq7

[Impel Pharmaceuticals @ImpelPharma]

We’re presenting 4 abstracts on Trudhesa® nasal spray, including assessments on drug-drug interactions with #gepants, at #AAN23. Looking forward to sharing new insights on acute #migraine treatment with the #neurology community in Boston!

Learn more: https://t.co/B2wu2skbJo